Related Experiment Video
Updated: Apr 3, 2026
06:49
The Rodent Model of Nonarteritic Anterior Ischemic Optic Neuropathy rNAION
Published on: November 20, 2016
9.6K
Nonarteritic Anterior Ischemic Optic Neuropathy: Review and Update
Osama H Ababneh1, Rahmeh K Al-Asmar2, Eva R Fashho2
1Neuro-Ophthalmology and Oculoplastic, Department of Ophthalmology, The University of Jordan and Jordan University Hospital, Amman, Jordan.
Neurologic Clinics
|April 1, 2026
Summary
Nonarteritic anterior ischemic optic neuropathy (NA-AION) causes vision loss in older adults due to poor blood flow to the optic nerve. Current treatments for this common condition are not definitive, highlighting a need for further research.
Area of Science:
- Ophthalmology
- Neurology
Background:
- Nonarteritic anterior ischemic optic neuropathy (NA-AION) is a leading cause of irreversible blindness in individuals over 50.
- It results from compromised blood supply to the optic nerve head.
Purpose of the Study:
- To summarize the current understanding of NA-AION, including its presentation, diagnosis, and management.
- To highlight the unmet need for effective treatments.
Main Methods:
- Review of existing literature on NA-AION.
- Clinical examination findings and diagnostic tools such as visual fields and optical coherence tomography (OCT) were considered.
Main Results:
- NA-AION typically presents as sudden, unilateral, painless vision loss with reduced visual acuity and visual field deficits.
- Diagnostic work-up involves patient history, clinical examination, and specialized tests.
Conclusions:
- Despite its prevalence, definitive treatment options for NA-AION remain elusive.
- Further research into novel therapeutic strategies is warranted to address this significant cause of vision impairment.
Related Concept Videos
01:27Open Angle Glaucoma: Treatment
1.1K
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
1.1K
01:25Glaucoma: Overview
1.7K
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
1.7K
01:28Angle Closure Glaucoma: Treatment
1.6K
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
1.6K